Schedule 13G ownership disclosure

X4 PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98420X103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,633,204
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-22-000324
Form type
SC 13G/A
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Feb 14, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub